This ELISA kit provides quantitative measurement of Lipocalin-2 (LCN2/NGAL) in mouse samples, supporting immunological research into innate immune responses and tissue injury. Because LCN2 is an acute-phase protein whose expression can shift dramatically — from low baseline levels in healthy tissue to markedly elevated concentrations during infection, renal injury, or inflammation — this kit is designed to capture that dynamic range across diverse experimental models.
Detection Range: The 31.25–2000 pg/mL range accommodates the steep induction of LCN2 observed in mouse serum and tissue during inflammatory challenge, while still resolving baseline concentrations. Samples from LPS-stimulated or ischemia-reperfusion models will likely require dilution, whereas unstimulated controls can often be measured neat.
Sensitivity: At 15.625 pg/mL, the kit detects LCN2 in low-abundance conditions such as conditioned media from resting macrophages or neutrophils prior to activation, where secreted levels are minimal but biologically meaningful.
Sample Compatibility: Validation across serum, plasma, cell culture supernatants, and tissue homogenates enables researchers to correlate circulating LCN2 with local tissue expression and in vitro cellular output within a single study, critical for dissecting organ-specific innate immune responses.
Assay Efficiency: The 1–5 hour protocol and 50–100 µL sample volume accommodate small-volume mouse bleeds and limited primary cell supernatants, supporting longitudinal sampling in survival studies.
This kit is directly applicable to acute kidney injury biomarker research, sepsis modeling, and gut mucosal immunity studies.